ELECTRONIC CALCULATOR

Description

The electronic calculator is characterized by the presence of an oblong casing. WITH A SQUARE FRONT OUTLINE AND ROUNDED CORNERS. “THE CASING IS IMPLEMENTED INCLUDING A FRONT AND A BACK. “THE UPPER AND LOWER SIDES OF THE FRONT OF THE The casings are implemented transversely, convex, and inclined forwards, one towards the OTHER. THE SIDE SIDES OF THE FRONT OF THE HOUSING ARE IMPLEMENTED TRANSVERSELY Convex and inclined forwards and toward each other. The upper and lower sides of the part The rear of the casing are implemented transversely, convex, and inclined backwards, and one TOWARDS THE OTHER. THE SIDE SIDES OF THE REAR OF THE HOUSING ARE IMPLEMENTED TRANSVERSELY CONVEX AND INCLINED BACKWARDS AND TOWARDS EACH OTHER. ALONG THE UPPER, LOWER AND On the side of the electronic calculator, there is a seam between the front and back parts of the... CASING. “ON ONE REAR SIDE OF THE BACK OF THE CASING THERE IS A SQUARE SLOT WITH Rounded corner portions. There are rounded protrusions on one rear side of the part. REAR OF THE HOUSING.“ALONG THE UPPER, LOWER AND SIDE SIDES OF THE FRONT THERE IS A CLOSED SLOT ON THE CASING. ON ONE REAR SIDE OF THE BACK OF THE CASING THERE IS A CAP. Quadrangular with rounded corners and having inclined upper, lower, and lateral portions FORWARD AND OUTWARD. THERE ARE ROUNDED PROTUBERANCES ON THE REAR OF THE COVER. 76 (2016-12-10), PAGES 123-134, XP029883866, ISSN: 1474-4422, DOI: 10.1016 / S1474-4422 (16) 30331-3 ABSTRACT PROCEDURES, ANALYSIS Affected claims 11-22“Y NOVAK PETR ET AL: "CHARACTERISATION OF THE ANTIBODY RESPONSE TO AADVACI: THE FIRST-IN-KIND ACTIVE VACCINE AGAINST NEUROFIBRILLARY TAU PATHOLOGY", ALZHEIMER 'S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER' SASSOCIATION, VOL. 12, No. 7, 27 JULY 2016 (2016-07-27), XP029769276, ISSN: 1552-5260, DOI: 10. 1016 / J. JALZ.2016.06.649 ABSTRACT Reivindicaciones afectadas 11-22“Y ANONYMOUS: "NCT01850238 - SAFETY STUDY OF AADVAC1, A TAU PEPTIDE-KLH-CONJUGATE ACTIVE VACCINE TO TREAT ALZHEIMER' S DISEASE - TABULAR VIEW - CLINICALTRIALS. GOV", 12 OCTOBER 2015 (2015-10-12), XP055582958, RETRIEVED FROM THE INTERNET: URL:HTTPS: / / CLINICALTRIALS. GOV / CT2 / SHOW / RE CORD / NCT01850238 [RETRIEVED ON 2019-04- 24] THE WHOLE DOCUMENT Reivindicaciones afectadas 11-22“Y ABSTRACT, RESULTS, DISCUSSION Reivindicaciones afectadas 2,3,5-9,17-21“Y WO 2011 / 013034 A1 (PFIZER VACCINES LLC [US] ; SMITH III GEORGE JOSEPH [US] ET AL.) 3 FEBRUARY 2011 (2011-02-03) EXAMPLES Reivindicaciones afectadas 11-22“Y WO 2015 / 197823 A2 (CRUCELL HOLLAND BV [NL] ) 30 DECEMBER 2015 (2015-12- 30) THE QUERY SEQUENCE SEQ ID N0: 1 HAS 100 % INDENTITY (100 % SIMILARITY) OVER 21 POSITIONS IN A COMMON OVERLAP (RANGE (Q:S): 1-21:1-21) WITH SUBJECT GSP: BCK53858 (LENGTH: 21) FROM WO2015197823- A2 PUBLISHED ON 2015-12-30. THE QUERY SEQUENCE SEQ ID N0: 3 HAS 100 % IDENTITY (100% SIMILARITY) OVER 18 POSITIONS IN A COMMON OVERLAP (RANGE (Q:S) : 1-18:1-18) WITH SUBJECT GSP: BCK53879 (LENGTH: 18) FROM W02015197823-A2 PUBLISHED ON 2015-12-30. Reivindicaciones afectadas 11-22“X CLARA THEUNIS ET AL: "NOVEL PHOSPHO-TAU MONOCLONAL ANTIBODY GENERATED USING A LIPOSOMAL VACCINE, WITH ENHANCED RECOGNITION OF A CONFORMATIONAL TAUOPATHY EPITOPE", JOURNAL OF ALZHEIMER' S DISEASE, VOL. 56, No. 2, 24 JANUARY 2017 (2017-01-24), PAGES 585-599, XP055531434, NL ISSN: 1387-2877, DOI: 10.3233 / JAD-160695 Claims affected 1,4,10,22“Y ABSTRACT, RESULTS, DISCUSSION Claims affected 2,3,5-9,17-21“X WO 2012 / 0555933 A1 (AC IMMUNE SA [CH] ; PIHLGREN BOSCH) MAY 3, 2021 (2012-05-03) Claims affected 1,4,10,22“Y PAGE 6, PARAGRAPH 5 TABLE 0N PAGE 36 PAGE 8, PARAGRAPH 2 - PARAGRAPH 5 THE QUERY SEQUENCE SEQ ID NO: 2 HAS 100%; IDENTITY (100 % SIMILARITY) OVER 16 POSITIONS IN A COMMON OVERLAP (RANGE(Q:S) : 1-16:1-16) WITH SUBJECT GSP. AZV72902 (LENGTH: 16) FROM WO2012055933-A1 PUBLISHED ON 2012-05-03. Claims affected 2,3,5-9,17-21“AND VICTOR RAUL GOMEZ ROMAN ET AL: "THERAPEUTIC VACCINATION USING CATIONIC LIPOSOME-ADJUVANTED HIV TYPE 1 PEPTIDES REPRESENTING HLA-SUPERTYPE-RESTRICTED SUBDOMINANTS T CELL EPITOPES: SAFETY, IMMUNOGENICITY, AND FEASIBILITY IN GUINEA-BISSAU", AIDS RESEARCH AND HUMAN RETROVIRUSES., VOL. 29, No. 11, 1 NOVEMBER 2013 (2013-11-01), PAGES 1504-1512, XP055531600, US ISSN: 0889-2229, DOI : 10. 1089 / AID.2013.0076 ABSTRACT Reivindicaciones afectadas 1-10,17-22“Y MATYAS GARY R ET AL: "LIPOSOMES CONTAINING MONOPHOSPHORYL LIPID A: A POTENT ADJUVANT SYSTEM FOR INDUCING ANTIBODIES TO HEROIN HAPTEN ANALOGS", VACCINE, ELSEVIER, AMSTERDAM, NL, VOL. 13, No. 26,23 APRIL 2013 2013 (2013-04-23), PAGES 2804-2810, XP028558266, ISSN: 0264-410X, DOI : 10, 1016 / J. VACCINE, 2013.04.027 ABSTRACT Reivindicaciones afectadas 2-10,17-22“Y RUEDA FELIX ET AL: "EFFECT OF TLR LIGANDS CO-ENCAPSULATED WITH MULTIEPITOPIC ANTIGEN IN NANOLIPOSOMES TARGETED TO HUMAN DCS VIA FC RECEPTOR FOR CANCER VACCINES", IMMUNOBIOLOGY, URBAN UND FISCHER VERLAG, DE, VOL. 222, No. 11, 10 JUNE 2017 (2017-06-10), PAGES 989-997, XP085171661, ISSN: 0171-2985, DOI: 10. 1016 / J.IMBIO.2017.06.002 PAGE 996, LEFT-HAND COLUMN Claims affected 2-10,17-22“ Observations: THIS REPORT WAS BASED ON THE PCT INTERNATIONAL SEARCH REPORT OF THE OFFICE EUROPEAN PATENT WITH N° WO 2019 / 084118“ Date of completion of the report: October 4, 2021 Examiner: Vielka Yasmina Jimenez Rodriguez